Clinical trials sponsored by Jiangsu Hansoh Pharmaceutical Co., Ltd.

Phase breakdown

Conditions studied

Recruiting trials led by Jiangsu Hansoh Pharmaceutical Co., Ltd.

• A Study of HS-20094 in Overweight or Obese Participants
  NCT07057674 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• A Study of Hansoh (HS)-10502 in Patients With Advanced Solid Tumors
  NCT05740956 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• Evaluate the Safety and Pharmacokinetics/Pharmacodynamics and Food Effect of HS-20118
  NCT07033234 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Evaluate the Safety and Pharmacokinetics/Pharmacodynamics of HS-20118
  NCT06846710 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 9 locations
• Phase 1/2 Study of HS-10375 in Patients with Advanced or Metastatic Non-Small-Cell Lung Cancer(NSCLC)
  NCT05435248 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials is Jiangsu Hansoh Pharmaceutical Co., Ltd. recruiting for?

Jiangsu Hansoh Pharmaceutical Co., Ltd. is the lead sponsor of 5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.